Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Cinnamaldehyde Derivatives Inhibit Coxsackievirus B3-Induced Viral Myocarditis

  • Li, Xiao-Qiang (Department of Pharmacology, School of Pharmacy, Fourth Military Medical University) ;
  • Liu, Xiao-Xiao (Department of Pharmacology, School of Pharmacy, Fourth Military Medical University) ;
  • Wang, Xue-Ying (Department of Pharmacology, School of Pharmacy, Fourth Military Medical University) ;
  • Xie, Yan-Hua (Department of Natural Medicine and Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University) ;
  • Yang, Qian (Department of Natural Medicine and Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University) ;
  • Liu, Xin-Xin (Department of Natural Medicine and Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University) ;
  • Ding, Yuan-Yuan (Department of Natural Medicine and Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University) ;
  • Cao, Wei (Department of Natural Medicine and Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University) ;
  • Wang, Si-Wang (Department of Natural Medicine and Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University)
  • Received : 2016.03.28
  • Accepted : 2016.06.13
  • Published : 2017.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

The chemical property of cinnamaldehyde is unstable in vivo, although early experiments have shown its obvious therapeutic effects on viral myocarditis (VMC). To overcome this problem, we used cinnamaldehyde as a leading compound to synthesize derivatives. Five derivatives of cinnamaldehyde were synthesized: 4-methylcinnamaldehyde (1), 4-chlorocinnamaldehyde (2), 4-methoxycinnamaldehyde (3), ${\alpha}$-bromo-4-methylcinnamaldehyde (4), and ${\alpha}$-bromo-4-chlorocinnamaldehyde (5). Neonatal rat cardiomyocytes and HeLa cells infected by coxsackievirus B3 (CVB3) were used to evaluate their antiviral and cytotoxic effects. In vivo BALB/c mice were infected with CVB3 for establishing VMC models. Among the derivatives, compound 4 and 5 inhibited the CVB3 in HeLa cells with the half-maximal inhibitory concentrations values of $11.38{\pm}2.22{\mu}M$ and $2.12{\pm}0.37{\mu}M$, respectively. The 50% toxic concentrations of compound 4 and 5-treated cells were 39-fold and 87-fold higher than in the cinnamaldehyde group. Compound 4 and 5 effectively reduced the viral titers and cardiac pathological changes in a dose-dependent manner. In addition, compound 4 and 5 significantly inhibited the secretion, mRNA and protein expressions of inflammatory cytokines TNF-${\alpha}$, IL-$1{\beta}$ and IL-6 in CVB3-infected cardiomyocytes, indicating that brominated cinnamaldehyde not only improved the anti-vital activities for VMC, but also had potent anti-inflammatory effects in cardiomyocytes induced by CVB3.

Keywords

References

  1. Battistuzzi, G., Cacchi, S. and Fabrizi, G. (2003) An efficient palladium-catalyzed synthesis of cinnamaldehydes from acrolein diethyl acetal and aryl iodides and bromides. Org. Lett. 5, 777-780. https://doi.org/10.1021/ol034071p
  2. Beige, J., Weber, A., Engeli, S., Offermann, G., Distler, A. and Sharma, A. M. (1996) Angiotensinogen-M235T genotype and post-transplant hypertension. Nephrol. Dial. Transplant. 11, 1538-1541. https://doi.org/10.1093/ndt/11.8.1538
  3. Blauwet, L. A. and Cooper, L. T. (2010) Myocarditis. Prog. Cardiovasc. Dis. 52, 274-288. https://doi.org/10.1016/j.pcad.2009.11.006
  4. Cao, W., Xie, Y. H., Li, X. Q., Zhang, X. K., Chen, Y. T., Kang, R., Chen, X., Miao, S. and Wang, S. W. (2011) Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways. Basic Res. Cardiol. 106, 1207-1220. https://doi.org/10.1007/s00395-011-0199-3
  5. Chen, R., Zhou, H., Beltran, J., Malellari, L. and Chang, S. L. (2005) Differential expression of cytokines in the brain and serum during endotoxin tolerance. J. Neuroimmunol. 163, 53-72. https://doi.org/10.1016/j.jneuroim.2005.02.012
  6. Chiang, L. C., Chiang, W., Chang, M. Y., Ng, L. T. and Lin, C. C. (2002) Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res. 55, 53-62. https://doi.org/10.1016/S0166-3542(02)00007-4
  7. Cooper, L. T., Jr. (2009) Myocarditis. N. Engl. J. Med. 360, 1526-1538. https://doi.org/10.1056/NEJMra0800028
  8. De Logu, A., Loy, G., Pellerano, M. L., Bonsignore, L. and Schivo, M. L. (2000) Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res. 48, 177-185. https://doi.org/10.1016/S0166-3542(00)00127-3
  9. Dennert, R., Crijns, H. J. and Heymans, S. (2008) Acute viral myocarditis. Eur. Heart J. 29, 2073-2082. https://doi.org/10.1093/eurheartj/ehn296
  10. Ding, Y., Qiu, L., Zhao, G., Xu, J. and Wang, S. (2010) Influence of cinnamaldehyde on viral myocarditis in mice. Am. J. Med. Sci. 340, 114-120. https://doi.org/10.1097/MAJ.0b013e3181dd3b43
  11. Fabre, A. and Sheppard, M. N. (2006) Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart 92, 316-320.
  12. Feldman, A. M. and McNamara, D. (2000) Myocarditis. N. Engl. J. Med. 343, 1388-1398. https://doi.org/10.1056/NEJM200011093431908
  13. Gu, Y. and Tian, S. K. (2012) Olefination reactions of phosphorus-stabilized carbon nucleophiles. Top. Curr. Chem. 327, 197-238.
  14. Gui, J., Yue, Y., Chen, R., Xu, W. and Xiong, S. (2012) A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting $NF-{\kappa}B$ signaling. PLoS ONE 7, e46515. https://doi.org/10.1371/journal.pone.0046515
  15. Hayashi, K., Imanishi, N., Kashiwayama, Y., Kawano, A., Terasawa, K., Shimada, Y. and Ochiai, H. (2007) Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo. Antiviral Res. 74, 1-8. https://doi.org/10.1016/j.antiviral.2007.01.003
  16. Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W. and Yancy, C. W. (2009) 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119, 1977-2016. https://doi.org/10.1161/CIRCULATIONAHA.109.192064
  17. Kashimura, T., Kodama, M., Hotta, Y., Hosoya, J., Yoshida, K., Ozawa, T., Watanabe, R., Okura, Y., Kato, K., Hanawa, H., Kuwano, R. and Aizawa, Y. (2004) Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat. Virchows Arch. 444, 283-292. https://doi.org/10.1007/s00428-003-0925-9
  18. Liu, P. P. and Mason, J. W. (2001) Advances in the understanding of myocarditis. Circulation 104, 1076-1082. https://doi.org/10.1161/hc3401.095198
  19. Mall, G., Klingel, K., Albrecht, M., Seemann, M., Rieger, P. and Kandolf, R. (1991) Natural history of Coxsackievirus B3-induced myocarditis in ACA/Sn mice: viral persistence demonstrated by quantitative in situ hybridization histochemistry. Eur. Heart J. 12 Suppl D, 121-123.
  20. Matsumori, A., Crumpacker, C. S. and Abelmann, W. H. (1987) Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model. J. Am. Coll. Cardiol. 9, 1320-1325. https://doi.org/10.1016/S0735-1097(87)80472-2
  21. Matsumori, A., Tomioka, N. and Kawai, C. (1988) Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am. Heart J. 115, 1229-1232. https://doi.org/10.1016/0002-8703(88)90013-0
  22. Nishio, R., Matsumori, A., Shioi, T., Ishida, H. and Sasayama, S. (1999) Treatment of experimental viral myocarditis with interleukin-10. Circulation 100, 1102-1108. https://doi.org/10.1161/01.CIR.100.10.1102
  23. Nordqvist, A., Bjorkelid, C., Andaloussi, M., Jansson, A. M., Mowbray, S. L., Karlen, A. and Larhed, M. (2011) Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors. J. Org. Chem. 76, 8986-8998. https://doi.org/10.1021/jo201715x
  24. Reed, L. J. and Muench, H. (1938) A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493-497. https://doi.org/10.1093/oxfordjournals.aje.a118408
  25. Schultz, J. C., Hilliard, A. A., Cooper, L. T., Jr. and Rihal, C. S. (2009) Diagnosis and treatment of viral myocarditis. Mayo Clin. Proc. 84, 1001-1009. https://doi.org/10.1016/S0025-6196(11)60670-8
  26. Seong, I. W., Choe, S. C. and Jeon, E. S. (2001) Fulminant coxsackieviral myocarditis. N. Engl. J. Med. 345, 379. https://doi.org/10.1056/NEJM200108023450518
  27. Shen, Y., Kan, Q. C., Xu, W., Chu, Y. W. and Xiong, S. D. (2009) Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes. Iran. J. Allergy Asthma Immunol. 8, 1-9.
  28. Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komajda, M., Tavazzi, L., Smiseth, O. A., Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J. L., Nieminen, M. S., Pierard, L. and Remme, W. J.; Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur. Heart J. 26, 1115-1140. https://doi.org/10.1093/eurheartj/ehi204
  29. van Staden, L. F., Gravestock, D. and Ager, D. J. (2002) New developments in the Peterson olefination reaction. Chem. Soc. Rev. 31, 195-200. https://doi.org/10.1039/a908402i
  30. Wang, Y. F., Wang, X. Y., Ren, Z., Qian, C. W., Li, Y. C., Kaio, K., Wang, Q. D., Zhang, Y., Zheng, L. Y., Jiang, J. H., Yang, C. R., Liu, Q., Zhang, Y. J. and Wang, Y. F. (2009) Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis. Antiviral Res. 84, 150-158. https://doi.org/10.1016/j.antiviral.2009.08.004
  31. Wang, Y. X., da Cunha, V., Vincelette, J., White, K., Velichko, S., Xu, Y., Gross, C., Fitch, R. M., Halks-Miller, M., Larsen, B. R., Yajima, T., Knowlton, K. U., Vergona, R., Sullivan, M. E. and Croze, E. (2007) Antiviral and myocyte protective effects of murine interferon-$\beta$ and -${\alpha}_2$ in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice. Am. J. Physiol. Heart Circ. Physiol. 293, H69-H76. https://doi.org/10.1152/ajpheart.00154.2007
  32. Youn, H. S., Lee, J. K., Choi, Y. J., Saitoh, S. I., Miyake, K., Hwang, D. H. and Lee, J. Y. (2008) Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem. Pharmacol. 75, 494-502. https://doi.org/10.1016/j.bcp.2007.08.033
  33. Yuan, J., Bucher, J. R., Goehl, T. J., Dieter, M. P. and Jameson, C. W. (1992) Quantitation of cinnamaldehyde and cinnamic acid in blood by HPLC. J. Anal. Toxicol. 16, 359-362. https://doi.org/10.1093/jat/16.6.359
  34. Zhang, Y., Cao, W., Xie, Y. H., Yang, Q., Li, X. Q., Liu, X. X. and Wang, S. W. (2012) The comparison of $\alpha$-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms. Int. Immunopharmacol. 14, 107-113. https://doi.org/10.1016/j.intimp.2012.06.007
  35. Zhao, H., Xie, Y., Yang, Q., Cao, Y., Tu, H., Cao, W. and Wang, S. (2014) Pharmacokinetic study of cinnamaldehyde in rats by GC-MS after oral and intravenous administration. J. Pharm. Biomed. Anal. 89, 150-157. https://doi.org/10.1016/j.jpba.2013.10.044

Cited by

  1. Clinical effects of tanshinone IIA sodium sulfonate combined with trimetazidine and levocarnitine in the treatment of AVMC and its effects on serum TNF-α, IL-18 and IL-35 vol.16, pp.5, 2018, https://doi.org/10.3892/etm.2018.6671
  2. Gomisin G Suppresses the Growth of Colon Cancer Cells by Attenuation of AKT Phosphorylation and Arrest of Cell Cycle Progression vol.27, pp.2, 2017, https://doi.org/10.4062/biomolther.2018.054
  3. Trans-cinnamaldehyde suppresses microtubule detyrosination and alleviates cardiac hypertrophy vol.914, pp.None, 2017, https://doi.org/10.1016/j.ejphar.2021.174687